Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma - Archive ouverte HAL Access content directly
Journal Articles Blood Year : 2016

Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma

(1) , (1) , (1) , (1, 2) , (3, 1) , (1) , (4) , (5) , (6) , (7) , (1, 2) , (1, 2) , (1, 8) , (1) , (1)
1
2
3
4
5
6
7
8
Anne Moreau
  • Function : Author
  • PersonId : 1202589
Valérie Trichet
  • Function : Author
Selina Chen-Kiang
  • Function : Author
  • PersonId : 1065383

Abstract

Key Points • CD40L plus cytokines induces cell-cycle progression and loss of mitochondrial priming, leading to drug resistance in MCL. • CD40L plus cytokines mimics in situ molecular profiles and allows the development of new approaches by integrating the role of the microenvironment. Mantle cell lymphoma (MCL) accumulates in lymphoid organs, but disseminates early on in extranodal tissues. Although proliferation remains located in lymphoid organs only, suggesting a major role of the tumor ecosystem, few studies have assessed MCL microenvironment. We therefore cocultured primary circulating MCL cells from 21 patients several weeks ex vivo with stromal or lymphoid-like (CD40L) cells to determine which interactions could support their proliferation. We showed that coculture with lymphoid-like cells, but not stromal cells, induced cell-cycle progression, which was amplified by MCL-specific cytokines (insulin Q : 5-like growth factor-1, B-cell activating factor, interleukin-6, interleukin-10). Of interest, we showed that our model recapitulated the MCL in situ molecular signatures (ie, proliferation, NF-kB, and survival signatures). We further demonstrated that proliferating MCL harbored an imbalance in Bcl-2 family expression, leading to a consequent loss of mitochondrial priming. Of interesting, this loss of priming was overcome by the type II anti-CD20 antibody obinutuzumab, which counteracted Bcl-x L induction through NF-kB inhibition. Finally, we showed that the mitochondrial priming directly correlated with the sensitivity toward venetoclax and alkylating drugs. By identifying the microenvironment as the major support for proliferation and drug resistance in MCL, our results highlight a selective approach to target the lymphoma niche. (Blood. 2016;00(00):1-11)
Embargoed file
Embargoed file
Ne sera jamais visible
Loading...

Dates and versions

inserm-01405674 , version 1 (30-11-2016)
inserm-01405674 , version 2 (29-04-2020)

Identifiers

Cite

David Chiron, Céline Bellanger, Antonin Papin, Benoit Tessoulin, Christelle Dousset, et al.. Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma. Blood, 2016, ⟨10.1182/blood-2016-06-⟩. ⟨inserm-01405674v2⟩
182 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More